Rare Case Report Attributes MG in Elderly Man to COVID-19 Vaccine

Rare Case Report Attributes MG in Elderly Man to COVID-19 Vaccine

313039

Rare Case Report Attributes MG in Elderly Man to COVID-19 Vaccine

An 82-year-old man was diagnosed with myasthenia gravis (MG) shortly after receiving his second dose of the BioNTech/Pfizer COVID-19 vaccine, a case study reports. He lacked typical MG symptoms, but instead developed speech problems (dysarthria) and swallowing difficulties (dysphagia). “Diagnosis of COVID-19 vaccine associated new onset myasthenia gravis requires awareness and recognition of less common symptoms including dysarthria and dysphagia, and attention to timing of vaccination,” the researchers wrote. The report, “A Case of COVID-19…

You must be logged in to read/download the full post.